Alex Zhavoronkov, CEO of Insilico Medicine, highlighted the significance of AI in drug discovery: "We can't say we have the first AI discovered and designed molecule approved, but we may be the furthest along the path." His comments reflect the evolving landscape of biotechnology where AI plays a crucial role in developing new treatments, demonstrating optimism about the future of AI-assisted drug development even before regulations and approvals are finalized.
Chris Meier from the Boston Consulting Group emphasized the potential impact of AI on drug discovery by stating, "Using AI to do drug discovery could make an enormous difference for patients." This highlights the shift towards leveraging advanced technologies to significantly streamline the traditionally protracted and expensive process of drug development, promising a transformation in how new therapies reach the market.
#ai-in-healthcare #drug-discovery #biotechnology-innovations #insilico-medicine #pharmaceutical-industry
Collection
[
|
...
]